ClinicalTrials.gov
ClinicalTrials.gov Menu

The Study of Chest Infections in Infants Living in a Refugee Camp on the Thai-Burmese Border (ARI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00894764
Recruitment Status : Completed
First Posted : May 7, 2009
Last Update Posted : May 7, 2012
Sponsor:
Collaborator:
Wellcome Trust
Information provided by (Responsible Party):
University of Oxford

May 6, 2009
May 7, 2009
May 7, 2012
September 2007
April 2012   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00894764 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
The Study of Chest Infections in Infants Living in a Refugee Camp on the Thai-Burmese Border
A Clinical and Microbiological Study of Acute Respiratory Infections in Refugee Infants Living on the Thai-Burmese Border
This study will follow 1000 refugee infants from birth for two years. The aim of the study is to better understand why some children develop infections caused by the bacterium Streptococcus pneumoniae whilst others merely carry this organism asymptomatically at the back of the nose (in the nasopharynx). The investigators will also define which micro-organisms cause lower respiratory tract infections (e.g., pneumonia) in this population in order to implement appropriate interventions (e.g., vaccines). Infants will be reviewed monthly and a nasopharyngeal swab will be taken. A group of 250 mother-infant pairs will be studied in greater detail, to improve our understanding of the frequency and outcomes of nasopharyngeal carriage of Streptococcus pneumoniae. Monthly nasopharyngeal swabs will be collected from mothers and infants. The investigators will measure the infant immune response to Streptococcus pneumoniae carriage or disease by taking monthly blood samples. The investigators will make an assessment of the protective effect of antibodies acquired from the mother during pregnancy by taking blood from the mother and placenta at birth. An assessment of pneumococcal carriage in mothers will also be made to determine how frequently the bacterium is transmitted between family members. All lower respiratory tract infections will be documented, and the causative micro-organisms identified.

This project's central hypothesis is that acute lower respiratory infections (ALRI) are a common and significant cause of morbidity and mortality in young children living in Maela refugee camp on the Thai-Burmese border, and that this is reflective of the general situation in the developing world. Therefore, we aim to define the incidence, aetiology, and outcome of acute lower respiratory infections in this population. This will focus on Streptococcus pneumoniae and the factors associated with colonisation and invasive disease.

Additional objectives are to:

  1. Characterise the interaction between bacterial and viral pathogens and disease.
  2. Examine the dynamics of pneumococcal nasopharyngeal carriage, including transmission of strains between infants and their mothers.
  3. Determine the effect of the non-pathogenic members of the nasopharyngeal flora on colonisation with potential pathogens.
  4. Examine the role of passively transferred maternal pneumococcal antibodies in subsequent pneumococcal colonisation and disease in the infant.
  5. Document the development of pneumococcal antibodies in the infants over time and correlate these with pneumococcal carriage and infection episodes.
  6. Determine the risk factors associated with respiratory infection.
  7. Characterise the bacteria causing invasive non-respiratory infections.
  8. Conduct surveillance for influenza and in particular avian influenza A (H5N1) infection.
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Maela is a densely populated camp predominantly inhabited by refugees of the Karen ethnic group. It is located in hills adjoining the Burmese border 50 km north of Mae Sot. It is the largest of the camps on the Thai-Burmese border, housing around one-third of the total refugee population. Maela has a population of approximately 43,000 people, of which 20% are females of child bearing age. Women presenting for antenatal care at SMRU's clinic will be asked to take part in the study.
  • Childhood Pneumonia
  • Pneumococcal Carriage
Not Provided
  • Routine Follow Up
    Monthly nasopharyngeal swab for infant. Seen during acute illness.
  • Immunology
    Monthly nasopharyngeal swab for mother and infant. Serum sample taken from Infant. Seen during acute illness.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
1000
Same as current
April 2012
April 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  1. Infants born in SMRU antenatal clinic, Maela camp
  2. Written informed consent from the mother
Sexes Eligible for Study: All
Child, Adult, Older Adult
Yes
Contact information is only displayed when the study is recruiting subjects
Thailand
 
 
NCT00894764
SMRU_09-2007
Mahidol Approval: MUTM2007/036
OXTREC Approval: 031-06
No
Not Provided
Not Provided
University of Oxford
University of Oxford
Wellcome Trust
Principal Investigator: Francois Nosten, MD Shoklo Malaria Research Unit
University of Oxford
May 2012